Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-047834
Filing Date
2023-08-31
Accepted
2023-08-31 14:54:23
Documents
1
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12005
  Complete submission text file 0001209191-23-047834.txt   13516
Mailing Address C/O ERASCA, INC. 108035 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address
Varney Michael David (Reporting) CIK: 0001638647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40067 | Film No.: 231228479

Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Issuer) CIK: 0001822711 (see all company filings)

EIN.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations